{"id":"W1977589606","doi":"10.1002/cpt.10","title":"Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Riociguat; Nitric oxide; Cyclic guanosine monophosphate; Pulmonary hypertension; Medicine; Heme; Pharmacology; Soluble guanylyl cyclase; Vasodilation; cGMP-dependent protein kinase; Internal medicine; Cardiology; Chronic thromboembolic pulmonary hypertension; Chemistry; Guanylate cyclase; Biochemistry; Enzyme","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001002994,0.001480001,0.006257491,0.0004277538,0.0005034263,0.00006585137,0.0005874873,0.001999038,0.0003636752],"category_scores_gemma":[0.00007033226,0.001069101,0.001884581,0.0004218849,0.0009058487,0.0001576224,0.0004402341,0.002029539,0.0003350497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002840783,"about_ca_system_score_gemma":0.002246509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001368087,"about_ca_topic_score_gemma":0.000001417352,"domain_scores_codex":[0.9922671,0.00115636,0.002260714,0.002051862,0.0005953997,0.001668505],"domain_scores_gemma":[0.9937292,0.002606081,0.0007776836,0.001121572,0.0003782122,0.001387198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001825235,0.003873806,0.00005669626,0.005424576,0.005929364,0.003005318,0.000004592108,9.333453e-7,0.002310946,0.000006658639,0.01536465,0.9621972],"study_design_scores_gemma":[0.006444805,0.003515862,0.000284378,0.002474701,0.01819243,0.004849717,0.000004991373,0.003717054,0.0000350372,0.0004383982,0.9591461,0.000896492],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001468334,0.9846709,0.0001097064,0.003406517,0.004405908,0.005464956,0.0001040342,0.0002561306,0.0001134856],"genre_scores_gemma":[0.000723472,0.971563,0.000824337,0.01820368,0.005222754,0.0004224003,0.0009896108,0.0003805455,0.001670212],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9613007,"threshold_uncertainty_score":0.9997949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1788209408837836,"score_gpt":0.4487858328702332,"score_spread":0.2699648919864495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}